Susquehanna International Group
BIO icon

Susquehanna International Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Susquehanna International Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.15M Buy
7,700
+5,600
+267% +$1.61M ﹤0.01% 6018
2025
Q4 		$636K Sell
2,100
-900
-30% -$281K ﹤0.01% 8247
2025
Q3 		$841K Sell
3,000
-1,400
-32% -$381K ﹤0.01% 7762
2025
Q2 		$1.06M Buy
4,400
+2,300
+110% +$544K ﹤0.01% 7259
2025
Q1 		$511K Sell
2,100
-800
-28% -$241K ﹤0.01% 8858
2024
Q4 		$953K Sell
2,900
-4,300
-60% -$1.46M ﹤0.01% 7077
2024
Q3 		$2.41M Sell
7,200
-300
-4% -$95.3K ﹤0.01% 4926
2024
Q2 		$2.05M Sell
7,500
-16,700
-69% -$4.86M ﹤0.01% 5052
2024
Q1 		$8.37M Sell
24,200
-36,800
-60% -$12.1M ﹤0.01% 2863
2023
Q4 		$19.7M Buy
61,000
+26,400
+76% +$8.27M ﹤0.01% 1834
2023
Q3 		$12.4M Buy
34,600
+6,100
+21% +$2.35M ﹤0.01% 2287
2023
Q2 		$10.8M Sell
28,500
-1,300
-4% -$529K ﹤0.01% 2411
2023
Q1 		$14.3M Buy
29,800
+15,700
+111% +$7.35M ﹤0.01% 2042
2022
Q4 		$5.93M Sell
14,100
-19,300
-58% -$7.79M ﹤0.01% 2981
2022
Q3 		$13.9M Buy
33,400
+19,200
+135% +$9.57M ﹤0.01% 1777
2022
Q2 		$7.03M Buy
14,200
+3,100
+28% +$1.61M ﹤0.01% 2685
2022
Q1 		$6.25M Buy
11,100
+1,800
+19% +$1.09M ﹤0.01% 3266
2021
Q4 		$7.03M Sell
9,300
-13,200
-59% -$9.88M ﹤0.01% 3196
2021
Q3 		$16.8M Buy
22,500
+3,800
+20% +$2.85M ﹤0.01% 2172
2021
Q2 		$12M Buy
18,700
+12,100
+183% +$7.36M ﹤0.01% 2654
2021
Q1 		$3.77M Sell
6,600
-4,200
-39% -$2.49M ﹤0.01% 4470
2020
Q4 		$6.3M Sell
10,800
-1,900
-15% -$1.08M ﹤0.01% 3077
2020
Q3 		$6.55M Buy
12,700
+1,900
+18% +$962K ﹤0.01% 2729
2020
Q2 		$4.88M Buy
10,800
+1,600
+17% +$706K ﹤0.01% 3048
2020
Q1 		$3.23M Sell
9,200
-10,800
-54% -$3.97M ﹤0.01% 3170
2019
Q4 		$7.4M Sell
20,000
-700
-3% -$247K ﹤0.01% 2451
2019
Q3 		$6.89M Buy
20,700
+8,200
+66% +$2.67M ﹤0.01% 2342
2019
Q2 		$3.91M Sell
12,500
-135,700
-92% -$40.6M ﹤0.01% 3063
2019
Q1 		$45.3M Buy
148,200
+129,000
+672% +$34.8M 0.02% 683
2018
Q4 		$4.46M Buy
19,200
+17,900
+1,377% +$4.8M ﹤0.01% 2416
2018
Q3 		$407K Sell
1,300
-4,700
-78% -$1.46M ﹤0.01% 6901
2018
Q2 		$1.73M Sell
6,000
-6,300
-51% -$1.74M ﹤0.01% 4257
2018
Q1 		$3.08M Buy
12,300
+3,500
+40% +$891K ﹤0.01% 3220
2017
Q4 		$2.1M Sell
8,800
-3,800
-30% -$921K ﹤0.01% 3825
2017
Q3 		$2.8M Buy
12,600
+7,700
+157% +$1.73M ﹤0.01% 3336
2017
Q2 		$1.11M Buy
4,900
+1,700
+53% +$370K ﹤0.01% 5039
2017
Q1 		$638K Sell
3,200
-16,100
-83% -$3.1M ﹤0.01% 6033
2016
Q4 		$3.52M Buy
19,300
+9,700
+101% +$1.65M ﹤0.01% 2987
2016
Q3 		$1.57M Sell
9,600
-9,000
-48% -$1.37M ﹤0.01% 3957
2016
Q2 		$2.66M Buy
18,600
+2,100
+13% +$300K ﹤0.01% 3107
2016
Q1 		$2.26M Buy
16,500
+9,500
+136% +$1.25M ﹤0.01% 3546
2015
Q4 		$971K Sell
7,000
-4,500
-39% -$624K ﹤0.01% 5459
2015
Q3 		$1.54M Sell
11,500
-700
-6% -$101K ﹤0.01% 4810
2015
Q2 		$1.84M Sell
12,200
-4,700
-28% -$672K ﹤0.01% 4905
2015
Q1 		$2.29M Buy
16,900
+12,000
+245% +$1.49M ﹤0.01% 4063
2014
Q4 		$591K Sell
4,900
-3,900
-44% -$449K ﹤0.01% 6906
2014
Q3 		$998K Sell
8,800
-6,200
-41% -$735K ﹤0.01% 5924
2014
Q2 		$1.8M Buy
15,000
+10,700
+249% +$1.31M ﹤0.01% 4866
2014
Q1 		$551K Sell
4,300
-100
-2% -$12.8K ﹤0.01% 6574
2013
Q4 		$544K Sell
4,400
-8,400
-66% -$1.02M ﹤0.01% 6553
2013
Q3 		$1.5M Buy
12,800
+4,300
+51% +$507K ﹤0.01% 4591
2013
Q2 		$954K Buy
+8,500
New +$997K ﹤0.01% 5071

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group's BIO Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Bio-Rad Laboratories Class A (BIO) in Q1 2026: 2,938 shares worth $819K. The stake represents ﹤0.01% of the portfolio and ranks #8416 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in BIO as recently as Q3 2025.

Susquehanna International Group first reported a position in BIO in Q2 2013 and has held it in 38 quarters since. The position peaked at $16.9M in Q2 2019. 393 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Susquehanna International Group held 2,938 shares of Bio-Rad Laboratories Class A worth $819K as of Q1 2026.
  • Bio-Rad Laboratories Class A was a new Susquehanna International Group position in Q1 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8416 holding.
  • Susquehanna International Group first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 38 quarters since.
  • Susquehanna International Group's Bio-Rad Laboratories Class A position peaked at $16.9M in Q2 2019.
  • 393 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.